id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-290378-h4cof32m	Guy, Tiphaine	High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU	2020-08-28		.txt	text/plain	1389	77	54	SARS-CoV2 infected patients with non-hypercapnic acute hypoxemic respiratory failure can benefit from HFNO outside an ICU. Patients infected with SARS-CoV-2 can develop severe pneumonia and respiratory failure, which often require treatment in intensive care units (ICU) in Western European countries (2) . This report describes the use of HFNO to manage SARS-CoV-2 infected patients with respiratory failure on the pulmonology ward rather than in an ICU. The theoretical risk of virus aerosolization resulted in early published reports of critically ill SARS-CoV-2-infected patients in China not recommending the use of HFNO or non-invasive ventilation until the patient had been cleared of COVID-19 (4). While these results should be confirmed in larger studies, we believe that our data strongly suggest that SARS-CoV2 infected patients with non-hypercapnic acute hypoxemic respiratory failure can benefit from HFNO outside an ICU.	./cache/cord-290378-h4cof32m.txt	./txt/cord-290378-h4cof32m.txt